SRBCF Financials: Sirona Biochem Corp. AI Analysis

Home

Stock

SRBCF

Financials

SRBCF Financial

Sirona Biochem Corp.

At close: Mar 24, 16:00:00 GMT-4

Post-market: Mar 24, 18:09:30 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0051

Open

$0.0051

Day's Range

$0.0051 - $0.0051

52 week range

$0.0001 - $0.0213

Volume

15.0K

Avg.Volume

593

Dividend yield

EPS (TTM)

-0.01

Market Cap

$1.3M

What is Sirona Biochem Corp.?

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-07-10. The company specializes in stabilizing carbohydrate molecules. The company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two advanced programs are the cosmetic skin lightener and diabetes drug. Other projects include the development of an anti-aging / cell protection library, a novel anti-wrinkle compound, and the launch of an anti-viral program. Its TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. The company is focused on three antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its subsidiary is TFChem S.A.R.L.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

SRBCF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	2	1	3	1	2	3
Research & Development	2	1	1	1	1	1
Operating Expenses	4	2	4	2	4	4
Other Non Operating Income (Expenses)	0	0	--	--	--	--
Pretax Income	-4	-2	-3	-2	-4	-4
Income Tax Expense	0	0	0	0	0	0
Net Income	-4	-2	-3	-2	-4	-4
Net Income Growth	100%	-33%	50%	-50%	0%	300%
Shares Outstanding (Diluted)	258.64	252.1	241.03	229.21	226.02	201.23
Shares Change (YoY)	3%	5%	5%	1%	12%	17%
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.01	-0.02
EPS Growth	98%	-32%	47%	-45%	-19%	204.99%
Free Cash Flow	-2	-1	-2	-2	-2	-3
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-4	-2	-3	-2	-4	--
EBITDA Margin	0%	0%	0%	0%	0%	--
D&A For EBITDA	0	0	0	0	0	--
EBIT	-4	-2	-3	-2	-4	-4
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Sirona Biochem Corp.'s key financial statements?



According to the latest financial statement (Form-10K), Sirona Biochem Corp. has a total asset of $1, Net loss of $-2

What are the key financial ratios for SRBCF?



Sirona Biochem Corp.'s Current ratio is 0.33, has a Net margin is 0, sales per share of $0.

How is Sirona Biochem Corp.'s revenue broken down by segment or geography?



Currently Sirona Biochem Corp. data is not available.

Is Sirona Biochem Corp. profitable?



no, according to the latest financial statements, Sirona Biochem Corp. has a net loss of $-2

Does Sirona Biochem Corp. have any liabilities?



yes, Sirona Biochem Corp. has liability of 3

How many outstanding shares for Sirona Biochem Corp.?



Sirona Biochem Corp. has a total outstanding shares of 253.6

Sirona Biochem Corp. (SRBCF) Financial

SRBCF Stock Price Chart